Melanoma tissue bank aims to personalize cancer treatment
NCT ID NCT01205815
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 38 times
Summary
This study collects and stores tissue and blood samples from 3,000 melanoma patients to identify biological changes linked to the start and spread of the disease. The goal is to help doctors and patients make more informed treatment decisions based on each tumor's unique molecular features. Participants provide leftover tissue from biopsies or surgeries and a small blood sample.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Vanderbitl-Ingram Cancer Center
RECRUITINGNashville, Tennessee, United States
Contact
Contact Phone: •••-•••-••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could help doctors choose more effective treatments for melanoma patients based on their tumor's molecular profile.
What could go wrong
This is an observational study, not a treatment trial. It may not directly benefit participants, and results may take years to influence clinical practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.